CH532123A - Verfahren zur Reinigung oder Konzentrierung von Tierviren- Suspensionen und Verwendung der erhaltenen Viren - Google Patents

Verfahren zur Reinigung oder Konzentrierung von Tierviren- Suspensionen und Verwendung der erhaltenen Viren

Info

Publication number
CH532123A
CH532123A CH580068A CH580068A CH532123A CH 532123 A CH532123 A CH 532123A CH 580068 A CH580068 A CH 580068A CH 580068 A CH580068 A CH 580068A CH 532123 A CH532123 A CH 532123A
Authority
CH
Switzerland
Prior art keywords
purification
concentration
animal virus
virus suspensions
viruses obtained
Prior art date
Application number
CH580068A
Other languages
German (de)
English (en)
Inventor
David Kanarek Alexander
William Tribe George
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of CH532123A publication Critical patent/CH532123A/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16151—Methods of production or purification of viral material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16211—Influenzavirus B, i.e. influenza B virus
    • C12N2760/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16211—Influenzavirus B, i.e. influenza B virus
    • C12N2760/16251—Methods of production or purification of viral material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
    • C12N2760/18534—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
    • C12N2760/18551—Methods of production or purification of viral material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18611—Respirovirus, e.g. Bovine, human parainfluenza 1,3
    • C12N2760/18634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/36011—Togaviridae
    • C12N2770/36211—Rubivirus, e.g. rubella virus
    • C12N2770/36234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CH580068A 1967-04-19 1968-04-19 Verfahren zur Reinigung oder Konzentrierung von Tierviren- Suspensionen und Verwendung der erhaltenen Viren CH532123A (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB1797667 1967-04-19

Publications (1)

Publication Number Publication Date
CH532123A true CH532123A (de) 1972-12-31

Family

ID=10104487

Family Applications (1)

Application Number Title Priority Date Filing Date
CH580068A CH532123A (de) 1967-04-19 1968-04-19 Verfahren zur Reinigung oder Konzentrierung von Tierviren- Suspensionen und Verwendung der erhaltenen Viren

Country Status (10)

Country Link
BE (1) BE713942A (en:Method)
CH (1) CH532123A (en:Method)
DE (1) DE1767220A1 (en:Method)
DK (1) DK122896B (en:Method)
ES (1) ES352868A1 (en:Method)
FR (1) FR1560875A (en:Method)
GB (1) GB1226743A (en:Method)
IL (1) IL29770A (en:Method)
NL (1) NL6805558A (en:Method)
YU (1) YU34714B (en:Method)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7216091A (en:Method) * 1971-12-03 1973-06-05
NZ197553A (en) * 1980-07-01 1985-03-20 Nat Res Dev Production of antigens specific to r.s.v.;cell lines bearing these antigens and pharmaceutical compositions

Also Published As

Publication number Publication date
YU86668A (en) 1979-07-10
DK122896B (da) 1972-04-24
FR1560875A (en:Method) 1969-03-21
BE713942A (en:Method) 1968-10-21
DE1767220A1 (de) 1971-08-19
IL29770A0 (en) 1968-06-20
IL29770A (en) 1971-10-20
YU34714B (en) 1979-12-31
ES352868A1 (es) 1969-09-01
GB1226743A (en:Method) 1971-03-31
NL6805558A (en:Method) 1968-10-21

Similar Documents

Publication Publication Date Title
CH525224A (de) Verfahren zur Herstellung von Indolverbindungen und deren Verwendung
CH441814A (de) Verfahren zur kontinuierlichen Bestimmung der Konzentration von Faseraufschwemmungen
AT332431B (de) Verfahren zur aufbereitung von mull und/oder schlamm
CH478916A (de) Verfahren zur Herstellung von Viren-Abwehrstoffen
CH473389A (de) Mehrkomponentiges Reagenz zum Nachweis von Harnsäure und dessen Verwendung
CH530396A (de) Verfahren zur Herstellung von N-Phenylindolinderivaten und deren Verwendung
CH456580A (de) Verfahren zur Herstellung von Nitroalkyladamantanen und deren Verwendung
AT307447B (de) Verfahren zur Anreicherung und Reinigung von gelösten Proteinen
CH532123A (de) Verfahren zur Reinigung oder Konzentrierung von Tierviren- Suspensionen und Verwendung der erhaltenen Viren
CH451698A (de) Verfahren zur photochemischen Unlöslichmachung von Polykondensaten
AT279036B (de) Verfahren zur Stabilisierung von Ascorbinsäure und deren Derivaten
AT245901B (de) Verfahren und Vorrichtung zur Regenerierung von Salzsäure
CH484113A (de) Verfahren zur Herstellung von Isoindolonen und deren Verwendung
AT303073B (de) Verfahren und Vorrichtung zur Filtration von Suspensionen
CH464216A (de) Verfahren zur Herstellung von Benzodiazocinen und deren Homologen
CH524623A (de) Verfahren zur Herstellung von Triazaadamantan-Derivaten und deren Verwendung
CH540338A (de) Verfahren zur Anreicherung und Reinigung einer Viren der Influenzagruppe enthaltenden Suspension und deren Verwendung zur Herstellung von inaktivierten Viren
CH462466A (de) Verfahren zur Herstellung von Polyalkylenterephthalaten und deren Verwendung
CH396908A (de) Verfahren zur Seitenkettenchlorierung von 2-Methyl-pyridinen und 2-Methyl-chinolinen
CH460001A (de) Verfahren zur Herstellung von Sulfoxid-Zinnkomplexverbindungen und deren Verwendung
CH507208A (de) Verfahren zur Reinigung und Gewinnung von Lysozym
CH522578A (de) Verfahren zur Herstellung von Ketonen und deren Verwendung
CH484149A (de) Verfahren zur Herstellung von Imidazolidonen und deren Verwendung
CH473096A (de) Verfahren zur Herstellung von Carbamaten und deren Verwendung
AT245546B (de) Verfahren zur Trennung geradkettiger von verzweigtkettigen und/oder cyclischen Kohlenwasserstoffen

Legal Events

Date Code Title Description
PL Patent ceased